Drug Topics - October 8, 2007 - (Page 28)

28 DRUG TOPICS OCTOBER 8, 2007 www.drugtopics.com Self-Care Vitamins for vision: The eyes have it Sandra Levy et ready for a slew of vitamins and supplements that are intended to promote eye health. Here’s a sampling: Bausch & Lomb is premiering Ocuvite DF, a product intended to provide nutritional support for people with diabetes. The supplement contains genistein, a compound found in soy, as well as alpha lipoic acid, vitamins C and E, and B vitamins. According to John Stewart, Bausch & Lomb’s senior product manager for nutritionals, preclinical studies have shown that high levels of genistein slow the progression of blood vessel growth in the retina. “Diabetic retinopathy is a vascular disease of the retina. It is the leading cause of vision loss in the working age population in the United States. About 10% of people who have Type 2 diabetes get diabetic retinopathy,” he said. This year, Ocuvite DF will be available in CVS, Walgreens, Rite Aid, Longs, and WalMart stores. Early next year, Ocuvite DF will be available to distributors serving independent pharmacies. Emphasizing that people with high glucose levels are subject to higher levels of oxidative stress, Stewart said, “When you have oxidative stress, you have free radical production and tissue damage. You need to take potent antioxidants. If diabetes patients can reduce or eliminate oxidative stress, they are less likely to get complications from diabetes like eye, liver, and kidney problems.” Bausch & Lomb is providing pharmacists with a one-page, front and back education piece, which explains the role of oxidative stress as well as Ocuvite DF’s ingredients. DSM Nutritional Products is also elbowing into eye health territory with Optisharp with zeaxanthin. The company claims zeaxanthin plays a role in reducing the risk of certain eye diseases such as age-related macular degeneration and cataracts. Bayer HealthCare is hoping to hit a home run with Bayer Nutritional Science Eye Health & Vitality, a product intended to help maintain eye health by supporting healthy cells and tissue. It contains vitamins A, C, and E and calcium, selenium, copper, a lutein/ G zeaxanthin blend, bilberry powder (leaf ), blueberry juice powder (fruit), carrot juice powder (root), and tomato juice powder (fruit). Windmill is getting into the act with Prevention Vision Support tablets that contain lutein and zeaxanthin. Alcon’s chance for trumping the competition is ICaps Eye Vitamin & Mineral Supplement. It is available in three formulations. The first formula is ICaps MV, a vitamin and mineral supplement that provides high doses of lutein and zeaxanthin. Alcon claims that ICaps MV does not contain vitamin A and that it is suitable for consumers who must avoid betacarotene. ICaps Lutein & Zeaxanthin is the second formula available. It contains antioxidants including vitamins A, C, and E plus selenium, zinc, lutein, and zeaxanthin. The product is formulated for people at risk of age-related eye conditions. The company claims it may also be appropriate for people with frequent exposure to sunlight. ICaps AREDS is the third formula. Ingredients include vitamins A, C, and E and zinc and copper. Nature’s Bounty is making available Diabetes Support Pack Multivitamin & Mineral Supplement. The supplement that is intended to promote eye health contains a multivitamin with lutein, alpha lipoic acid, cinnamon and chromium picolinate, selenium, folic acid, CoQ10, and vitamin C. Douglas Laboratories is introducing Ocu-Omega, a dietary supplement intended for patients who want to support optimal eye function. The supplement is a liquidfilled, two-piece capsule sealed with a band that contains a combination of lutein, zeaxanthin, and omega-3 fatty acids from ultrapure, molecularly distilled fish oil. Hi-Tech Pharmacal’s Health Care Products division is offering Multi-betic Multi-Vitamin Tablets, with vitamins, minerals, alpha lipoic acid, and lutein. Finally, Advanced Vision Research markets TheraTears, a nutritional supplement with omega 3 that is intended for the treatment of dry eye. DT http://www.drugtopics.com

Table of Contents Feed for the Digital Edition of Drug Topics - October 8, 2007

Drug Topics - October 8, 2007 Latebreakers Latebreakers in Depth Letters Rx Care Community Practice JP at Large 150 Years of American Pharmacy Hospital Practice Are You Getting Pharmacy's Message Across? Self-Care Government and Law Legal Q&A The Pharmacist as First Responder in Disaster Relief Technology Update New Products Advertisers Index Statement of Ownership Classified Viewpoint

Drug Topics - October 8, 2007

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.